These findings unravel the mechanism of 4‐HNE in GPX4‐dependent ferroptosis and identify OTUD5 as a novel therapeutic target for the treatment of myocardial ischemia/reperfusion injury. This evidence concerns the gene OTUD5 and myocardial ischemia.